Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · Real-Time Price · USD
12.35
-0.08 (-0.64%)
At close: Dec 5, 2025, 4:00 PM EST
12.25
-0.10 (-0.81%)
After-hours: Dec 5, 2025, 7:59 PM EST
Mind Medicine (MindMed) Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 45.29 | 38.62 | 41.74 | 30.16 | 58.77 | 14.4 | |
| Research & Development | 105.9 | 65.3 | 52.12 | 36.17 | 34.79 | 18.63 | |
| Operating Expenses | 151.19 | 103.92 | 93.87 | 66.33 | 93.55 | 33.03 | |
| Operating Income | -151.19 | -103.92 | -93.87 | -66.33 | -93.55 | -33.03 | |
| Interest Expense | -4.87 | -2.28 | -0.92 | - | -0.36 | -0.16 | |
| Interest & Investment Income | 10.75 | 11.56 | 5.58 | 1.5 | - | - | |
| Currency Exchange Gain (Loss) | -0.16 | -0.64 | 0.16 | 0.2 | -0.09 | 0.13 | |
| Other Non Operating Income (Expenses) | -22.63 | -15.94 | -6.69 | 7.85 | 0.11 | -0.87 | |
| EBT Excluding Unusual Items | -168.1 | -111.22 | -95.73 | -56.8 | -93.89 | -33.94 | |
| Merger & Restructuring Charges | - | - | - | - | -0.3 | - | |
| Other Unusual Items | - | 2.54 | - | - | - | - | |
| Pretax Income | -168.1 | -108.68 | -95.73 | -56.8 | -94.19 | -33.94 | |
| Income Tax Expense | - | - | - | - | -1.16 | - | |
| Net Income | -168.1 | -108.68 | -95.73 | -56.8 | -93.04 | -33.94 | |
| Net Income to Common | -168.1 | -108.68 | -95.73 | -56.8 | -93.04 | -33.94 | |
| Shares Outstanding (Basic) | 85 | 70 | 39 | 31 | 27 | 18 | |
| Shares Outstanding (Diluted) | 85 | 70 | 39 | 31 | 27 | 18 | |
| Shares Change (YoY) | 42.97% | 79.94% | 26.90% | 12.71% | 54.25% | 159.06% | |
| EPS (Basic) | -1.98 | -1.54 | -2.44 | -1.84 | -3.40 | -1.91 | |
| EPS (Diluted) | -1.98 | -1.54 | -2.44 | -1.84 | -3.40 | -1.91 | |
| EBITDA | -151.67 | -103.89 | - | -66.32 | -93.54 | -32.48 | |
| D&A For EBITDA | -0.48 | 0.03 | - | 0.02 | 0.02 | 0.55 | |
| EBIT | -151.19 | -103.92 | -93.87 | -66.33 | -93.55 | -33.03 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.